Stanford University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).
Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.
Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.
Top-decile sponsor footprint
Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,744 total, page 21 of 35
Sildenafil for the Treatment of Lymphatic Malformations
NCT02335242
Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI
NCT02893293
Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy
NCT02369835
Optimizing Fidelity to Family-Based Treatment for Adolescent Anorexia Nervosa
NCT02139462
Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling
NCT02437084
Pharmacokinetic (PK) and Pharmacodynamic (PD) Modeling of Ampicillin and Gentamicin in Peripartum Patients
NCT02427932
Postoperative Respiratory Monitoring After Neuraxial Opioid Administration for Cesarean Delivery
NCT02417038
Clinical Trial of Manganese-Enhanced MRI (MEMRI) to Assess Peri-Infarct Injury
NCT02933034
68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer
NCT02440308
Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration
NCT02422160
Effects of Social Gaze Training on Brain and Behavior in Fragile X Syndrome
NCT02616796
Self-Administered Lidocaine Gel for Pain Management With First Trimester Surgical Abortion: A Randomized Controlled Trial
NCT02447029
Epidemiologic Study of Hepatocellular Carcinoma in the US
NCT02358070
Contrast-Enhanced Digital Mammography(CEDM) vs Contrast-Enhanced Breast MRI(CE-MRI) in Breast Cancer
NCT01970670
Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy
NCT02432820
NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer
NCT02429804
Adjunct Interpersonally Focused Psychodynamic Group Psychotherapy for Residual Depression Symptoms
NCT02449499
Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients
NCT02643862
Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation
NCT02376387
Parents Workgroup About Emotion Regulation
NCT02400177
Non-steroidal Anti-inflammatory Affect on Kidneys in Endurance Distances
NCT02272725
Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease
NCT02458898
Multispectral Imaging to Characterize Patterns of Vascular Supply Within Lymphoepithelial Mucosa in Oropharyngeal Cancer
NCT02365844
A Disposable Device NAS to Treat Obstructive Sleep Apnea and Snoring
NCT02928770
A Study to Investigate Cystic Fibrosis Pulmonary Exacerbations and the Lung Microbiome
NCT05088447
Localized Therapeutics for the Treatment of Gastrointestinal Disorders
NCT02290665
Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin Resistance
NCT03509441
Quality of Life in Adults Impaired Functioning - A Randomized Controlled Trial of Bidet vs Usual Toileting
NCT02042157
Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood
NCT02650206
Social Motivation Intervention for Children With Autism Spectrum Disorder: Improving Peer Initiation
NCT02360449
Adaptive Closed Loop Neuromodulation and Neural Signatures of Parkinson's Disease
NCT02384421
Brief Behavioral Intervention for Insomnia During Chemotherapy
NCT02165839
Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU
NCT02343575
Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis
NCT02442960
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
NCT02312882
Perioperative Recovery of Moods, Opioids, and Pain Trial (PROMPT)
NCT02070003
Use of PET/MR Imaging in Chronic Pain
NCT03195270
Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)
NCT03028987
Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation
NCT02424955
Study of an Electronic Health Record-embedded Severe Sepsis Early Warning Alert
NCT02376842
Integrative Personal Omics Profiling for Dynamic Molecular Phenotypes Monitoring During Fiber Supplementation
NCT04706858
Genetic and Environmental Factors in the Response to Influenza Vaccination
NCT03088904
Pharmacology of Aminophylline for Acute Kidney Injury in Neonates
NCT02276170
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection
NCT03453801
Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)
NCT03028974
Molecular and Cellular Analysis of Breast Cancer
NCT02243397
Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women
NCT01965704
Innovative Physical Activity Interventions for Overweight Latinos
NCT02385591
Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy
NCT02058550
Omega-3 Supplementation for Smell Dysfunction
NCT02529332
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 209 |
| Phase 3 | 51 |
| Phase 4 | 86 |
Therapeutic Areas
What is open in the Stanford University pipeline
264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).
Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.